Biotransformaciones de Antitumorales y Antimalariales Artemisininas

Biotransformaciones de Antitumorales y Antimalariales Artemisininas

by Igor A. Parshikov

Browse books you can read free on Readfeed

No club is reading this yet — be the first to start one

Start a club free
About
This book describes examples of the use of microbial technologies for the preparation of artemisinin derivatives. There are considered some examples of the formation of various metabolites depending of the composition of the nutrient medium. The production of new derivatives of artemisinins with greater antimalarial and antitumor activity is an important research task in the field of microbial biotechnology and medical chemistry. (Book in Spanish) Igor A. Parshikov. Biotransformaciones de Antitumorales y Antimalariales Artemisininas. – Dallas: Primedia E-launch LLC, 2019. − 30 p.

Discuss Biotransformaciones de Antitumorales y Antimalariales Artemisininas with other readers

Join or start a book club for Biotransformaciones de Antitumorales y Antimalariales Artemisininas on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Biotransformaciones de Antitumorales y Antimalariales Artemisininas?

Sign up free on Readfeed, then browse public clubs or start your own club with Biotransformaciones de Antitumorales y Antimalariales Artemisininas as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Biotransformaciones de Antitumorales y Antimalariales Artemisininas with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Biotransformaciones de Antitumorales y Antimalariales Artemisininas with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.